Cardiovascular effects of growth hormone in adult hemodialysis patients: Results from a randomized controlled trial

Nephron - Clinical Practice

Volumn 115, Issue 3, 2010, Pages

  Kober, Lars ^a   Rustom, Rana ^c   Wiedmann, Jonas ^c   Kappelgaard, Anne Marie ^b   El Nahas, Meguid ^d   Feldt Rasmussen, Bo ^a  

^a Rigshospitalet   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Cholesterol; Growth hormone; Hemodialysis; Lean body mass

Indexed keywords

GHRELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HUMAN GROWTH HORMONE; INTERLEUKIN 6; PLACEBO; TRANSFERRIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; BEDTIME DOSAGE; BODY MASS; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE TACHYCARDIA; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMORRHAGIC SHOCK; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPOTENSION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEOPLASM; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SEPSIS; SPINAL CORD ISCHEMIA; SUBDURAL HEMATOMA; SYSTOLIC BLOOD PRESSURE; VEIN OCCLUSION; VEIN THROMBOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 77951082540     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313038     Document Type: Article

References (15)

1. de Jager DJ, Grootendorst DC, Jager KJ, et al: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789.
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):S112-S119.
3. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS, HEMO Study Group: Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65: 2380-2389.
4. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(suppl):S16-S23.
5. McDonald S, Chang S, Excell L: Australia and New Zealand dialysis and transplant registry. http://www.anzdata.org.au/anzdata/ AnzdataReport/ 30thReport/ContentsandSummary. pdf (accessed April 2, 2008).
6. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
7. Foley RN, Murray AM, Li S, et al: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
8. Weiner DE, Tighiouart H, Stark PC, et al: Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44: 198-206.
9. Wing AJ, Broyer M, Brunner FP, et al: Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc 1983; 20: 2-75.
10. Kennedy R, Case C, Fathi R, Johnson D, Isbel N, Marwick TH: Does renal failure cause an atherosclerotic milieu in patients with endstage renal disease Am J Med 2001; 110: 198-204.
11. Di Benedetto A, Marcelli D, D'Andrea A, et al: Risk factors and underlying cardiovascular diseases in incident ESRD patients. J Nephrol 2005; 18: 592-598.
12. Mak RH, Pak YK: End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int 1996; 50: 400-406.
13. Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM: Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994; 46: 1178-1183.
14. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991; 2: 1130-1135.
15. Garibotto G, Barreca A, Russo R, et al: Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997; 99: 97-105.